Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity
https://www.biorxiv.org/content/10.1101/2020.05.21.109157v1
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding
https://www.medrxiv.org/content/10.1101/2020.05.27.20114652v1
We are keenly focused on how cells remodel their extracellular proteome in health and disease. To understand and disrupt human disease-associated signaling processes, we develop enabling technologies with protein & antibody engineering and site-directed small molecule approaches.
Recent news
| Dec 14th, 2019 |
Last Christmas Party of the decade!    |
| Nov 25th, 2019 |
Farewell to Duy Nguyen!  |
| Nov 4th, 2019 |
Great dinner at CCB retreat with Wiita lab!  |
| Sept 10, 2019 | Go Giants at our annual game outing! |
|
Aug 27, 2019 |
Farewell and best wishes to Professor Amy Weeks.  |
|
Jul 31, 2019 |
Welcome Julia Xu to the world!  |
|
Jun 27, 2019 |
 Thanks to the Quantitative Biosciences Institute (QBI) for their initiative to get to know each private investigator. Details: Interview with Jim Wells. |
|
Jun 26, 2019 |
Congrats and thanks to Ninwe Maraha for our lab being awarded the LivingGreen certification from the Office of Sustainability. Details: School of Pharmacy leads in LivingGreen certifications.  |
| Mar 17, 2019 |
Congrats to Cole Bracken for passing his qualifying exam.  |
More: News